SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Nuclear Medicine

• Publication date

  1994-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 8294990
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PET analysis of alcohol interaction with the brain disposition of [11C]flumazenil

  2005cited by this paper
• Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics

  2005cited by this paper
• Computer‐Assisted Coregistration of Multislice SPECT and MR Brain Images by Fixed External Fiducials

  1993cited by this paper
• Single photon emission tomography measurement of benzodiazepine receptor number and affinity in primate brain: a constant infusion paradigm with [123I]iomazenil.

  1993cited by this paper
• Measurement of Benzodiazepine Receptor Number and Affinity in Humans Using Tracer Kinetic Modeling, Positron Emission Tomography, and [11C]Flumazenil

  1993cited by this paper
• Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: Is selective loss of glutamatergic neurons associated with major psychoses?

  1993cited by this paper
• Dynamic SPECT imaging after injection of the benzodiazepine receptor ligand [123I]iomazenil in healthy human subjects.

  1992cited by this paper
• Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics

  1992cited by this paper
• “Central” and “peripheral” benzodiazepine receptors

  1992cited by this paper
• SPECT imaging of the benzodiazepine receptor in non-human primate brain with [123I]Ro 16-0154.

  1991cited by this paper
• Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography

  1991cited by this paper
• Regional Brain Measurement of Bmax and KD with the Opiate Antagonist Cyclofoxy: Equilibrium Studies in the Conscious Rat

  1991cited by this paper
• Precision and Accuracy Considerations of Physiological Quantitation in PET

  1991cited by this paper
• Differentiation of Radioligand Delivery and Binding in the Brain: Validation of a Two-Compartment Model for [11C]Flumazenil

  1991cited by this paper
• Quantitative in vivo analysis of benzodiazepine binding sites in the human brain using positron emission tomography.

  1991cited by this paper
• In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors.

  1990cited by this paper
• Quantitative evaluation of benzodiazepine receptors in live Papio papio baboons using positron emission tomography.

  1990cited by this paper
• Brain perfusion SPECT using an annular single crystal camera: initial clinical experience.

  1990cited by this paper
• Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium Analysis

  1989cited by this paper
• Multicompartmental Analysis of [11C]-Carfentanil Binding to Opiate Receptors in Humans Measured by Positron Emission Tomography

  1989cited by this paper
• Plasma binding and transport of diazepam across the blood-brain barrier. No evidence for in vivo enhanced dissociation.

  1989cited by this paper
• Benzodiazepine receptors in normal human brain, in Parkinson's disease and in progressive supranuclear palsy.

  1988cited by this paper
• In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci.

  1988cited by this paper
• Regional Specific Binding of [11C]RO 15 1788 to Central Type Benzodiazepine Receptors in Human Brain: Quantitative Evaluation by PET

  1988cited by this paper
• Changes in benzodiazepine receptors in alzheimer‐type dementia

  1988cited by this paper
• Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

  1986cited by this paper
• Visualization of specific binding sites of benzodiazepine in human brain.

  1986cited by this paper
• Quantitative in vivo receptor binding. I. Theory and application to the muscarinic cholinergic receptor

  1985cited by this paper
• Neurotransmitter receptor alterations in Huntington's disease: Autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes

  1985cited by this paper
• Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography.

  1985cited by this paper
• Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography.

  1985cited by this paper
• Central type benzodiazepine binding sites: a positron emission tomography study in the baboon's brain.

  1984cited by this paper
• Benzodiazepine and GABA receptors in early Huntington's disease

  1984cited by this paper
• A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

  1984cited by this paper
• Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations.

  1984cited by this paper
• [3H]R05-4864 and [3H]flunitrazepam binding in kainate-lesioned rat striatum and in temporal cortex of brains from patients with senile dementia of the Alzheimer type.

  1983cited by this paper
• Quantitative autoradiography of neurotransmitter receptors in Huntington disease

  1982cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method

  1979cited by this paper
• Benzodiazepine receptor: demonstration in the central nervous system

  1977cited by this paper
• High densities of benzodiazepine receptors in human cortical areas

  1977cited by this paper

• Ligand-Enabled Copper-Mediated Radioiodination of Arenes

  2024cites this paper
• Bolus infusion scheme for the adjustment of steady state [11C]Flumazenil levels in the grey matter and in the blood plasma for neuroreceptor imaging

  2020cites this paper
• Rapidly (and Successfully) Translating Novel Brain Radiotracers From Animal Research Into Clinical Use

  2020cites this paper
• An open‐label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)‐(–)‐O‐desmethylvenlafaxine and racemic O‐desmethylvenlafaxine

  2018cites this paper
• Brain translocator protein occupancy by ONO‐2952 in healthy adults: A Phase 1 PET study using [11C]PBR28

  2017cites this paper
• Challenges and opportunities in quantitative brain PET imaging

  2017cites this paper
• Contribution of neuroinflammation to changes in [11C]flumazenil binding in the rat brain: Evaluation of the inflamed pons as reference tissue.

  2017cites this paper
• PET y SPECT de neurotransmisión cerebral PET and SPECT of cerebral neurotransmission

  2016cites this paper
• In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients.

  2015cites this paper
• Imaging the "GABA shift" in schizophrenia.

  2015cites this paper
• Quantification of GABAA receptors in the rat brain with [(123)I]Iomazenil SPECT from factor analysis-denoised images.

  2014cites this paper
• Cocaine Abuse in Humans Is Not Associated with Increased Microglial Activation: An 18-kDa Translocator Protein Positron Emission Tomography Imaging Study with [11C]PBR28

  2014cites this paper
• Evaluation of cerebral function using iomazenil SPECT for patients with traumatic brain injury.

  2013cites this paper
• 18F-FPEB, a PET Radiopharmaceutical for Quantifying Metabotropic Glutamate 5 Receptors: A First-in-Human Study of Radiochemical Safety, Biokinetics, and Radiation Dosimetry

  2013cites this paper
• Sex‐specific differences in GABAA‐benzodiazepine receptor availability: relationship with sensitivity to pain and tobacco smoking craving

  2013cites this paper
• benzodiazepine receptors Neuron loss after coronary artery bypass detected by SPECT estimation of

  2013cites this paper
• Reproducibility of Post-Amphetamine [11C]FLB 457 Binding to Cortical D2/3 Receptors

  2013cites this paper
• PET Imaging of Nicotinic Acetylcholine Receptors in Baboons with 18F-AZAN, a Radioligand with Improved Brain Kinetics

  2012influential citation
• Radiotracer properties determined by high performance liquid chromatography: a potential tool for brain radiotracer discovery.

  2012cites this paper
• [11C]flumazenil Binding Is Increased in a Dose-Dependent Manner with Tiagabine-Induced Elevations in GABA Levels

  2012cites this paper
• Synthesis and characterization of two pet radioligands for the metabotropic glutamate 1 (mGlu1) receptor

  2012cites this paper
• Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: Quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone

  2012cites this paper
• Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.

  2011cites this paper
• Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone

  2011cites this paper
• Evaluation of dopamine D2/3specific binding in the cerebellum for the positron emission tomography radiotracer [11C]FLB 457: Implications for measuring cortical dopamine release

  2011cites this paper
• Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependence.

  2011cites this paper
• Dopaminergic mechanisms of target detection - P300 event related potential and striatal dopamine.

  2011cites this paper
• Diazepam-Induced Changes in EEG Oscillations During Performance of a Sustained Attention Task

  2011cites this paper
• Positron emission tomography imaging of dopamine D2/3 receptors in the human cortex with [11C]FLB 457: Reproducibility studies

  2011cites this paper
• Development of novel radiotracers as tools for imaging the human brain

  2011cites this paper
• Imaging of dopamine D2/3 agonist binding in cocaine dependence: A [11C]NPA positron emission tomography study

  2011cites this paper
• Imaging receptor changes in human drug abusers.

  2010cites this paper
• Dynamic single photon emission computed tomography—basic principles and cardiac applications

  2010cites this paper
• A Comparative Evaluation of the Dopamine D2/3 Agonist Radiotracer [11C](−)-N-Propyl-norapomorphine and Antagonist [11C]Raclopride to Measure Amphetamine-Induced Dopamine Release in the Human Striatum

  2010cites this paper
• Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study

  2010cites this paper
• No effect of dopamine depletion on the binding of the high‐affinity D2/3 radiotracer [11C]FLB 457 in the human cortex

  2010cites this paper
• Positron emission tomography imaging of D2/3 agonist binding in healthy human subjects with the radiotracer [11C]‐N‐propyl‐norapomorphine: Preliminary evaluation and reproducibility studies

  2009cites this paper
• GABAA‐benzodiazepine receptor availability in smokers and nonsmokers: Relationship to subsyndromal anxiety and depression

  2009cites this paper
• Positron emission tomography imaging of amphetamine‐induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride

  2009cites this paper
• Tiagabine Increases [11C]flumazenil Binding in Cortical Brain Regions in Healthy Control Subjects

  2009cites this paper
• Quantification of nicotinic acetylcholine receptors in the human brain with PET: Bolus plus infusion administration of 2-[18F]F-A85380

  2008cites this paper
• Effect of aging on cerebral A1 adenosine receptors: A [18F]CPFPX PET study in humans.

  2007cites this paper
• gamma-Aminobutyric acid-serotonin interactions in healthy men: implications for network models of psychosis and dissociation.

  2006cites this paper
• A1 adenosine receptor PET using [18F]CPFPX: Displacement studies in humans

  2006cites this paper
• Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods.

  2006cites this paper
• NUCLEAR NEUROLOGY Iodine-123-lomazenil and Iodine-123- lodoamphetamine SPECT in Major Cerebral Artery Occlusive Disease

  2006cites this paper
• Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635

  2006cites this paper
• Positron Emission Tomography Quantification of [11C]-Harmine Binding to Monoamine Oxidase-A in the Human Brain

  2006cites this paper
• SPECT quantification of benzodiazepine receptor concentration using a dual-ligand approach.

  2006cites this paper
• Quantification of cerebral A1 adenosine receptors in humans using [18F]CPFPX and PET: an equilibrium approach

  2005cites this paper
• Effects of reduced endogenous 5‐HT on the in vivo binding of the serotonin transporter radioligand 11C‐DASB in healthy humans

  2005cites this paper
• Effect of reconstruction and filtering on kinetic parameter estimation bias and reliability for dynamic SPECT: a simulation study

  2005cites this paper
• Cortical γ-aminobutyric acid type A-benzodiazepine receptors in recovery from alcohol dependence : Relationship to features of alcohol dependence and cigarette smoking

  2005cites this paper
• Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652.

  2005cites this paper
• Analysis of neuroreceptor PET-data based on cytoarchitectonic maximum probability maps: a feasibility study

  2005cites this paper
• SPECT quantification of benzodiazepine receptor concentration and ligand affinity using a dual-ligand approach

  2005cites this paper
• Neuroreceptor imaging in psychiatry: theory and applications.

  2005cites this paper
• Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia

  2005cites this paper
• Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB.

  2005cites this paper
• Cortical gamma-aminobutyric acid type A-benzodiazepine receptors in recovery from alcohol dependence: relationship to features of alcohol dependence and cigarette smoking.

  2005cites this paper
• Nicotinic Acetylcholine Receptors in Human Brain by the Constant Infusion Paradigm: Feasibility and Reproducibility

  2005cites this paper
• Carbon-11 and iodine-123 labelled iomazenil: a direct PET-SPET comparison

  2005influential citation
• Quantification of Cerebral A1 Adenosine Receptors in Humans using [18F]CPFPX and PET

  2004cites this paper
• Quantitative Analysis of ( (cid:1) )- N - 11 C-Propyl-Norapomorphine In Vivo Binding in Nonhuman Primates

  2004cites this paper
• A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA).

  2004cites this paper
• Effect of amphetamine on [18F]fallypride in vivo binding to D2 receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies

  2004influential citation
• Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans.

  2004cites this paper
• Benzodiazepine receptor distribution in severe intractable tinnitus.

  2004cites this paper
• In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates

  2004cites this paper
• Ligand Tracer Kinetics: Theory and Application

  2004cites this paper
• The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics.

  2004cites this paper
• Central type benzodiazepine receptors in Gulf War veterans with posttraumatic stress disorder.

  2004cites this paper
• Evaluation of the use of a standard input function for compartment analysis of [123I]iomazenil data: Factors influencing the quantitative results

  2004cites this paper
• In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐raclopride

  2004cites this paper
• Quantitative analysis of (-)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primates.

  2004cites this paper
• PET y SPECT de neurotransmisión cerebral

  2003cites this paper
• Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT.

  2003cites this paper
• Pharmacological evaluation of (S)-8-[123I]iodobretazenil: a radioligand for in vivo studies of central benzodiazepine receptors.

  2003cites this paper
• Imaging Studies in Substance Abuse

  2003cites this paper
• Quantification of 5-HT2A Receptors in the Human Brain Using [18F]Altanserin-PET and the Bolus/Infusion Approach

  2003cites this paper
• Positron emission tomography: imaging and quantification of neurotransporter availability.

  2002cites this paper
• Drug interactions at GABA(A) receptors.

  2002cites this paper
• Neuron loss after coronary artery bypass detected by SPECT estimation of benzodiazepine receptors.

  2002cites this paper
• Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia

  2002cites this paper
• Evaluation of the Reference Tissue Models for PET and SPECT Benzodiazepine Binding Parameters

  2002cites this paper
• Quantification of [123I]PE2I binding to dopamine transporters with SPET

  2002cites this paper
• Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635.

  2002cites this paper
• Comparative Evaluation in Nonhuman Primates of Five PET Radiotracers for Imaging the Serotonin Transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM

  2002cites this paper
• Synthesis and pharmacological characterization of a new PET ligand for the serotonin transporter: [11C]5-bromo-2-[2-(dimethylaminomethylphenylsulfanyl)]phenylamine ([11C]DAPA).

  2002cites this paper
• CPD - education and self-assessment: functional imaging in epilepsy.

  2001cites this paper
• An introduction to PET and SPECT neuroreceptor quantification models.

  2001cites this paper
• Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography: I. Accuracy and Precision of D2 Receptor Parameter Measurements in Ventral Striatum

  2001cites this paper
• Differential Occupancy of Somatodendritic and Postsynaptic 5HT1A Receptors by Pindolol: A Dose-Occupancy Study with [11C]WAY 100635 and Positron Emission Tomography in Humans

  2001cites this paper
• Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers.

  2001cites this paper
• The role of model-based methods in the development of single scan techniques.

  2000cites this paper
• Similarity and Robustness of PET and SPECT Binding Parameters for Benzodiazepine Receptors

  2000cites this paper
• Bildgebende Forschung bei Drogenmißbrauch

  2000cites this paper
• Benzodiazepine receptor deficiency and tinnitus.

  2000cites this paper
• Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder.

  2000cites this paper
• In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652.

  2000cites this paper